MB Trademark
Trademark Overview
On Thursday, November 17, 2022, a trademark application was filed for MB with the United States Patent and Trademark Office. The USPTO has given the MB trademark a serial number of 97681878. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 30, 2024. This trademark is owned by Mainline Biosciences (Shanghai) Co., Ltd.. The MB trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the prevention of cancer or tumor; Pharmaceutical preparations for the treatment and prevention of cancer or tumor; Pharmaceutical preparations for the treatment of cancer or tumor; Pharmaceutical preparations for cancer or tumor; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer or tumor
Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Testing of pharmaceuticals
General Information
| Serial Number | 97681878 |
| Word Mark | MB |
| Filing Date | Thursday, November 17, 2022 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, July 30, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, June 4, 2024 |
Trademark Statements
| Description of Mark | The mark consists of a stylized "M" to the left of a stylized "B". |
| Goods and Services | Pharmaceutical preparations for the prevention of cancer or tumor; Pharmaceutical preparations for the treatment and prevention of cancer or tumor; Pharmaceutical preparations for the treatment of cancer or tumor; Pharmaceutical preparations for cancer or tumor; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer or tumor |
| Pseudo Mark | MAINLINE BIOSCIENCES |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Testing of pharmaceuticals |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 8, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 8, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Mainline Biosciences (Shanghai) Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Lingang, Shanghai 201413
CN |
| Party Name | Mainline Biosciences (Shanghai) Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Lingang, Shanghai 201413
CN |
Trademark Events
| Event Date | Event Description |
| Monday, November 21, 2022 | NEW APPLICATION ENTERED |
| Thursday, December 8, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 30, 2023 | ASSIGNED TO EXAMINER |
| Friday, September 1, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, September 1, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, September 1, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 1, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 22, 2024 | ASSIGNED TO LIE |
| Monday, April 22, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 22, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, April 30, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, April 30, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, April 30, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, April 30, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, April 30, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 15, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 4, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 4, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 30, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Saturday, November 30, 2024 | TEAS STATEMENT OF USE RECEIVED |
